DOCS 分类 A Doximity, Inc. Class A Common Stock
NYSE · Health Care · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 6, 2026DOCS 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
DOCS 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
关于 Doximity, Inc. Class A Common Stock 公司概况(来自维基百科)
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.
History
The company was launched in March 2011 by co-founders Nate Gross, Jeff Tangney and Shari Buck. In 2013, founder Jeff Tangney remained CEO while the company was based in San Mateo, California. By 2013, it became one of the largest networks for U.S. healthcare professionals, with approximately 10 percent of U.S. doctors as members.
By the beginning of 2014, 40 percent of U.S. physicians became members. In 2016, it began offering a free service for doctors to call patients using their work number on their mobile phones. In 2018, the company announced that it had reached 1 million members, accounting for more than 70 percent of U.S. physicians. In 2021, Doximity served more than 2 million registered members, including over 80 percent of U.S. physicians and over 50 percent of nurse practitioners and physician assistants.
In 2016, the company was ranked #6 on the Deloitte Technology Fast 500 list. In November 2019, Doximity was listed on the Deloitte Technology Fast 500 list for the fourth consecutive year. In May 2020, the company added video. Dialer Video, a video telehealth app, allows physicians to video call patients through personal smartphones. In June 2020, Doximity Acquires THMED and launches the Curative Brand. Curative is a staffing and recruiting company offering permanent and Locum/Temporary placement services.
In May 2021, Doximity, a professional network for physicians with telehealth and scheduling tools, filed for an initial public offering (IPO) seeking to raise $100 million. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities were the lead underwriters for the IPO. Doximity raised nearly $606 million in its IPO. In its June 2021 IPO on the NYSE, gave it a market cap shortly after its debut of $9.4 billion.
In 2021 August, CNBC reported that the site's news feed was "inundated" with vaccine misinformation shared among physicians, despite Doximity's community guidelines banning medical misinformation. At the time, 80% of its revenue came from ads paid by pharmaceutical firms and hospitals, and directed at physicians on the site. In November 2023, Doximity released DocDefender, a free service that removed a physician's personal phone numbers and addresses from public websites.
Investors
In April 2014, the company announced it had raised a $54 million financing round led by the venture capital firm Draper Fisher Jurvetson and the mutual fund company T. Rowe Price. Morgan Stanley Investment Management also invested. This investment brought Doximity's total funding to $81 million. Doximity received $10.8 million in venture capital funding from Emergence Capital Partners and Interwest Partners in March 2011, and $17 million in Series B funding led by Morgenthaler Ventures in September 2012.
Products and services
Dialer
In 2016, Doximity built Dialer, a free communication tool for physicians to call their patients. The Doximity Dialer app allows physicians to call patients from their personal cell phone, and the patient sees the doctor's office number on caller ID.
Dialer Video
In May 2020, Doximity released Dialer Video, a telemedicine tool that allows physicians to video call their patients directly from their own smartphones. In July 2020, Doximity said that more than 100,000 U.S. Doctors use Dialer Video, its telemedicine app.
Acquisition
In June 2020, Doximity acquired THMED, a healthcare company. Following the purchase, THMED changed its name to Curative and started concentrating on customized medical-personnel queries. In February 2022, Doximity acquired Amion, an on-call doctor scheduling company. In August 2025, Doximity acquired Pathway Medical, a Canadian startup specializing in medical AI and evidence-based clinical reference tools.
来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
| 指标 | 5年趋势 | DOCS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | 33.25年均值 ≈49.8 | ≈49.8 | · | · | |
| P/S (TTM) | 7.75年均值 ≈16.1 | ≈16.1 | · | · | |
| 市净率 (MRQ) | 5.55年均值 ≈7.6 | ≈7.6 | · | · | |
| Price / FCF (股价/自由现金流) | 15.75年均值 ≈39.2 | ≈39.2 | · | · | |
| Price / Cash Flow (市现率) | 15.75年均值 ≈38.9 | ≈38.9 | · | · | |
| 市净率(有形资产) (MRQ) | 5.75年均值 ≈8.3 | ≈8.3 | · | · | |
| PEG Ratio (市盈率增长比) | ≈1.0 | · | · | · |
同行中位数按每项指标的标准化基础计算,可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | DOCS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 毛利率 (TTM) | 88.1%5年均值 ≈88.9% | ≈88.9% | · | · | |
| 营业利润率 (TTM) | 29.6%5年均值 ≈34.1% | ≈34.1% | · | · | |
| 息税折旧摊销前利润率 (TTM) | 32.0%5年均值 ≈36.2% | ≈36.2% | · | · | |
| 税前利润率 (TTM) | 34.5%5年均值 ≈37.8% | ≈37.8% | · | · | |
| 净利润率 (TTM) | 25.5%5年均值 ≈34.5% | ≈34.5% | · | · | |
| ROA (TTM) | 14.6%5年均值 ≈16.9% | ≈16.9% | · | · | |
| ROE (TTM) | 17.2%5年均值 ≈17.4% | ≈17.4% | · | · | |
| ROIC | 17.7%5年均值 ≈15.7% | ≈15.7% | · | · |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | DOCS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 6.15年均值 ≈6.9 | ≈6.9 | · | · | |
| Quick Ratio (速动比率) | 2.35年均值 ≈1.9 | ≈1.9 | · | · |
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | DOCS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 13.1%5年均值 ≈26.9% | ≈26.9% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 15.4%5年均值 ≈21.9% | ≈21.9% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 25.5% | · | · | · | |
| EPS YoY | -11.7%5年均值 ≈51.7% | ≈51.7% | · | · | |
| Net Income YoY (净利润同比增长) | -12.2%5年均值 ≈50.2% | ≈50.2% | · | · | |
| EPS CAGR 3Y (每股收益年复合增长率(3年)) | 22.7%5年均值 ≈28.5% | ≈28.5% | · | · | |
| EPS CAGR 5Y (每股收益年复合增长率(5年)) | 33.6% | · | · | · | |
| Net Income CAGR 3Y (净利润年复合增长率(3年)) | 20.2%5年均值 ≈25.5% | ≈25.5% | · | · | |
| Net Income CAGR 5Y (净利润年复合增长率(5年)) | 31.3% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | DOCS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.55年均值 ≈0.5 | ≈0.5 | · | · | |
| Receivables Turnover (应收账款周转率) | 4.75年均值 ≈4.8 | ≈4.8 | · | · | |
| Revenue / Employee (年营业收入 ÷ 员工人数(报告的 headcount,yfinance)。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$732.8K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | $0.29 | $0.31 | -6.7% | |
| 2026年3月31日 | $0.26 | $0.29 | -10.0% | |
| 2025年12月31日 | $0.46 | $0.45 | 1.2% | |
| 2025年9月30日 | $0.45 | $0.39 | 16.4% | |
| 2025年6月30日 | $0.36 | $0.31 | 17.5% | |
| 2025年3月31日 | $0.46 | $0.45 | 1.2% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $645M | $570M | $475M | $419M | $344M | $207M | $116M | |
| Cost of Revenue | $70M | $56M | $51M | $53M | $40M | $31M | $15M | |
| Gross Profit | $575M | $515M | $425M | $366M | $304M | $176M | $101M | |
| R&D Expense | $131M | $93M | $82M | $80M | $62M | $44M | $32M | |
| SG&A Expense | $65M | $46M | $38M | $37M | $36M | $16M | $7M | |
| Operating Expenses | $360M | $287M | $261M | $240M | $190M | $122M | $79M | |
| Operating Income | $215M | $228M | $164M | $125M | $114M | $53M | $22M | |
| Other Non-op | $-806.0K | $-247.0K | $62.0K | $-146.0K | $-448.0K | $4M | $1M | |
| Pretax Income | $250M | $264M | $185M | $133M | $114M | $58M | $24M | |
| Income Tax | $54M | $40M | $38M | $20M | $-41M | $8M | $-6M | |
| Net Income | $196M | $223M | $148M | $113M | $155M | $50M | $30M | |
| EPS (Basic) | $1.05 | $1.19 | $0.78 | $0.58 | $0.82 | $0.29 | $0.16 | |
| EPS (Diluted) | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | $0.23 | $0.13 | |
| Shares (Basic) | 187,014,000 | 186,841,000 | 190,172,000 | 193,176,000 | 163,484,000 | 74,342,000 | 66,758,000 | |
| Shares (Diluted) | 199,048,000 | 201,208,000 | 205,734,000 | 213,425,000 | 191,017,000 | 95,134,000 | 81,710,000 | |
| EBITDA | $229M | $238M | $174M | $135M | $119M | · | · |
资产负债表
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $219M | $210M | $97M | $158M | $113M | $66M | · | |
| Receivables | $145M | $128M | $101M | $107M | $81M | $50M | · | |
| Prepaid Expense | $51M | $45M | $49M | $27M | $19M | $11M | · | |
| Current Assets | $944M | $1.09B | $913M | $975M | $904M | $209M | · | |
| PP&E (Net) | $18M | $14M | $12M | $11M | $8M | $8M | · | |
| PP&E (Gross) | $49M | $39M | $31M | $25M | $17M | $12M | · | |
| Accum. Depreciation | $31M | $25M | $19M | $14M | $8M | $5M | · | |
| Goodwill | $85M | $68M | $68M | $68M | $19M | $19M | · | |
| Intangibles | $35M | $23M | $27M | $32M | $8M | $10M | · | |
| Other Non-current Assets | $2M | $2M | $1M | $2M | $2M | $3M | · | |
| Total Assets | $1.12B | $1.26B | $1.08B | $1.14B | $991M | $252M | · | |
| Accounts Payable | $4M | $1M | $2M | $1M | $463.0K | $2M | · | |
| Accrued Liabilities | $43M | $38M | $44M | $31M | $25M | $16M | · | |
| Current Liabilities | $155M | $156M | $147M | $140M | $111M | $102M | · | |
| Capital Leases | $8M | $10M | $12M | $14M | $447.0K | $284.0K | · | |
| Other Non-current Liabilities | $9M | $9M | $7M | $1M | $956.0K | $972.0K | · | |
| Total Liabilities | $173M | $182M | $178M | $171M | $113M | $104M | · | |
| Common Stock | $183.0K | $189.0K | $187.0K | $194.0K | $192.0K | $83.0K | · | |
| Paid-in Capital | $1.00B | $894M | $824M | $762M | $703M | $30M | · | |
| Retained Earnings | $-51M | $187M | $80M | $218M | $191M | $36M | · | |
| AOCI | $28.0K | $1M | $-3M | $-14M | $-15M | $-21.0K | · | |
| Stockholders' Equity | $951M | $1.08B | $901M | $966M | $879M | $67M | $1M | |
| Liabilities + Equity | $1.12B | $1.26B | $1.08B | $1.14B | $991M | $252M | · | |
| Shares Outstanding | 183,060,000 | 188,875,000 | 186,562,000 | 193,941,000 | 192,398,000 | 82,910,000 | · |
现金流
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| D&A | $14M | $11M | $10M | $10M | $5M | $4M | $900.0K | |
| Stock-based Comp | $122M | $72M | $51M | $48M | $31M | $7M | $2M | |
| Deferred Tax | $32M | $-12M | $-9M | $13M | $-41M | $5M | $-7M | |
| Amort. of Intangibles | $6M | $4M | $5M | $5M | $1M | $1M | $0 | |
| Restructuring | · | $2M | $8M | $0 | $0 | · | · | |
| Other Non-cash | $-38M | $-21M | $-16M | $-5M | $-23M | · | · | |
| Operating Cash Flow | $326M | $273M | $184M | $180M | $127M | $83M | $26M | |
| CapEx | $0 | $0 | $147.0K | $2M | $2M | $245.0K | $285.0K | |
| Investing Cash Flow | $147M | $-29M | $31M | $-60M | $-641M | $-70M | $-13M | |
| Stock Repurchased | $432M | $120M | $281M | $85M | $3M | $2M | $0 | |
| Net Stock Activity | $-432M | $-120M | $-281M | $-85M | $-3M | · | · | |
| Financing Cash Flow | $-464M | $-131M | $-277M | $-74M | $560M | $5M | $2M | |
| Net Change in Cash | $10M | $113M | $-61M | $45M | $46M | $18M | $15M | |
| Taxes Paid | $22M | · | · | · | · | · | · | |
| Free Cash Flow | $326M | $273M | $184M | $178M | $125M | · | · |
盈利能力
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% | · | · | |
| Operating Margin | 33.3% | 39.9% | 34.5% | 29.9% | 33.1% | · | · | |
| Net Margin | 30.4% | 39.1% | 31.0% | 26.9% | 45.1% | · | · | |
| Pretax Margin | 38.8% | 46.2% | 39.0% | 31.8% | 33.2% | · | · | |
| EBITDA Margin | 35.6% | 41.8% | 36.6% | 32.3% | 34.5% | · | · | |
| ROA | 16.4% | 19.1% | 13.3% | 10.6% | 24.9% | · | · | |
| ROE | 19.2% | 21.1% | 16.7% | 11.9% | 18.0% | · | · | |
| ROIC | 17.7% | 17.8% | 14.5% | 11.0% | 17.5% | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 7.0 | 6.2 | 7.0 | 8.1 | · | · | |
| Quick Ratio | 2.3 | 2.2 | 1.3 | 1.9 | 1.7 | · | · |
效率
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.4 | 0.4 | 0.6 | · | · | |
| Receivables Turnover | 4.7 | 5.0 | 4.6 | 4.5 | 5.2 | · | · |
每股
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.19 | $5.73 | $4.83 | $4.98 | $4.57 | · | · | |
| Revenue / Share | $3.24 | $2.83 | $2.31 | $1.96 | $1.80 | · | · | |
| Cash Flow / Share | $1.64 | $1.36 | $0.89 | $0.84 | $0.66 | · | · | |
| Cash / Share | $1.20 | $1.11 | $0.52 | $0.81 | $0.59 | · | · | |
| EPS (TTM) | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | · | · |
增长率
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.1% | 20.0% | 13.5% | 22.0% | 66.0% | · | · | |
| Revenue CAGR 3Y | 15.4% | 18.4% | 32.0% | · | · | · | · | |
| Revenue CAGR 5Y | 25.5% | · | · | · | · | · | · | |
| EPS YoY | -11.7% | 54.2% | 35.9% | -24.3% | 204.3% | · | · | |
| EPS CAGR 3Y | 22.7% | 16.6% | 46.3% | · | · | · | · | |
| EPS CAGR 5Y | 33.6% | · | · | · | · | · | · | |
| Net Income YoY | -12.2% | 51.2% | 30.8% | -27.1% | 208.3% | · | · | |
| Net Income CAGR 3Y | 20.2% | 13.0% | 43.2% | · | · | · | · | |
| Net Income CAGR 5Y | 31.3% | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $645M | $570M | $475M | $419M | $344M | · | · | |
| Net Income TTM | $196M | $223M | $148M | $113M | $155M | · | · | |
| Market Cap | $4.27B | $10.96B | $5.02B | $6.28B | $10.02B | · | · | |
| P/E | 23.8 | 52.3 | 37.4 | 61.1 | 74.4 | · | · | |
| P/S | 6.6 | 19.2 | 10.6 | 15.0 | 29.2 | · | · | |
| P/B | 4.5 | 10.1 | 5.6 | 6.5 | 11.4 | · | · | |
| P / Tangible Book | 5.1 | 11.1 | 6.2 | 7.2 | 11.8 | · | · | |
| P / Cash Flow | 13.1 | 40.1 | 27.3 | 35.0 | 79.2 | · | · | |
| P / FCF | 13.1 | 40.1 | 27.3 | 35.3 | 80.4 | · | · | |
| Earnings Yield | 4.2% | 1.9% | 2.7% | 1.6% | 1.3% | · | · |
损益表
| 指标 | 趋势 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $157M | $145M | $185M | $169M | $146M | $138M | $169M | $137M | $127M | $118M | $135M | $114M | $108M | $111M | $115M | $102M | |
| Cost of Revenue | $24M | $19M | $19M | $16M | $16M | $14M | $14M | $14M | $14M | $13M | $12M | $13M | $13M | $14M | $14M | $13M | |
| Gross Profit | $133M | $126M | $166M | $152M | $130M | $124M | $154M | $123M | $113M | $105M | $123M | $101M | $95M | $97M | $102M | $89M | |
| R&D Expense | $38M | $39M | $35M | $30M | $27M | $25M | $22M | $23M | $23M | $20M | $20M | $20M | $22M | $22M | $21M | $19M | |
| SG&A Expense | $16M | $16M | $18M | $19M | $12M | $13M | $14M | $10M | $9M | $10M | $10M | $9M | $9M | $10M | $10M | $9M | |
| Operating Expenses | $99M | $101M | $94M | $88M | $76M | $75M | $74M | $70M | $67M | $64M | $65M | $67M | $66M | $64M | $63M | $57M | |
| Operating Income | $34M | $25M | $72M | $64M | $55M | $49M | $80M | $53M | $46M | $42M | $59M | $34M | $30M | $33M | $38M | $32M | |
| Other Non-op | $-286.0K | $-235.0K | $-158.0K | $-178.0K | $-235.0K | $-51.0K | $-30.0K | $-114.0K | $-52.0K | $73.0K | $-55.0K | $-50.0K | $94.0K | $-27.0K | $-25.0K | $-48.0K | |
| Pretax Income | $40M | $32M | $81M | $73M | $64M | $58M | $90M | $62M | $53M | $48M | $63M | $40M | $35M | $37M | $41M | $33M | |
| Income Tax | $16M | $13M | $19M | $11M | $11M | $-4M | $15M | $18M | $12M | $7M | $15M | $9M | $6M | $6M | $7M | $7M | |
| Net Income | $24M | $19M | $62M | $62M | $53M | $62M | $75M | $44M | $41M | $41M | $48M | $31M | $28M | $31M | $33M | $26M | |
| EPS (Basic) | $0.13 | $0.11 | $0.33 | $0.33 | $0.28 | $0.33 | $0.40 | $0.24 | $0.22 | $0.21 | $0.26 | $0.16 | $0.15 | $0.15 | $0.17 | $0.14 | |
| EPS (Diluted) | $0.13 | $0.09 | $0.31 | $0.31 | $0.27 | $0.31 | $0.37 | $0.22 | $0.21 | $0.20 | $0.24 | $0.15 | $0.13 | $0.15 | $0.16 | $0.12 | |
| Shares (Basic) | 182,569,000 | · | 187,478,000 | 187,705,000 | 187,984,000 | · | 187,161,000 | 186,252,000 | 185,610,000 | · | 186,309,000 | 193,112,000 | 194,521,000 | · | 192,805,000 | 193,137,000 | |
| Shares (Diluted) | 191,169,000 | · | 199,224,000 | 200,745,000 | 201,158,000 | · | 202,233,000 | 200,407,000 | 199,224,000 | · | 200,463,000 | 209,014,000 | 212,355,000 | · | 212,065,000 | 213,949,000 | |
| EBITDA | $38M | · | $72M | $64M | $57M | · | $80M | $53M | $49M | · | $59M | $34M | $32M | · | $38M | $32M |
资产负债表
| 指标 | 趋势 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $274M | $219M | $65M | $169M | $137M | $210M | $165M | $184M | $111M | $97M | $123M | $108M | $307M | · | $136M | $74M | |
| Receivables | $178M | $145M | $157M | $129M | $142M | $128M | $138M | $125M | $121M | $101M | $98M | $97M | $93M | · | $75M | $79M | |
| Prepaid Expense | $49M | $51M | $102M | $85M | $52M | $45M | $30M | $27M | $37M | $49M | $27M | $33M | $20M | · | $17M | $16M | |
| Current Assets | $914M | $944M | $993M | $1.09B | $1.03B | $1.09B | $1.01B | $958M | $908M | $913M | $841M | $863M | $990M | · | $899M | $848M | |
| PP&E (Net) | $19M | $18M | $17M | $16M | $14M | $14M | $13M | $13M | $13M | $12M | $12M | $12M | $12M | · | $12M | $12M | |
| PP&E (Gross) | $53M | $49M | $47M | $43M | $41M | $39M | $37M | $35M | $33M | $31M | $29M | $28M | $26M | · | $24M | $22M | |
| Accum. Depreciation | $34M | $31M | $30M | $28M | $26M | $25M | $23M | $22M | $21M | $19M | $18M | $16M | $15M | · | $12M | $11M | |
| Goodwill | $85M | $85M | $85M | $85M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | · | $68M | $68M | |
| Intangibles | $33M | $35M | $37M | $39M | $22M | $23M | $24M | $25M | $26M | $27M | $28M | $29M | $31M | · | $33M | $34M | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $1M | · | $1M | $1M | |
| Total Assets | $1.08B | $1.12B | $1.16B | $1.26B | $1.20B | $1.26B | $1.17B | $1.12B | $1.07B | $1.08B | $1.00B | $1.03B | $1.15B | · | $1.07B | $1.03B | |
| Accounts Payable | $6M | $4M | $5M | $4M | $2M | $1M | $2M | $3M | $2M | $2M | $2M | $714.0K | $582.0K | · | $2M | $1M | |
| Accrued Liabilities | $33M | · | $77M | $34M | $38M | $38M | $43M | $34M | $28M | $44M | $34M | $29M | $32M | · | $33M | $26M | |
| Current Liabilities | $150M | $155M | $150M | $140M | $160M | $156M | $116M | $132M | $135M | $147M | $105M | $123M | $133M | · | $106M | $118M | |
| Capital Leases | $8M | $8M | $9M | $9M | $10M | $10M | $11M | $11M | $12M | $12M | $13M | $13M | $14M | · | $14M | $15M | |
| Other Non-current Liabilities | $10M | $9M | $19M | $12M | $9M | $9M | $9M | $8M | $7M | $7M | $841.0K | $7M | $6M | · | $1M | $1M | |
| Total Liabilities | $168M | $173M | $178M | $162M | $179M | $182M | $141M | $157M | $160M | $178M | $136M | $154M | $163M | · | $137M | $149M | |
| Common Stock | $180.0K | $183.0K | $185.0K | $188.0K | $187.0K | $189.0K | $188.0K | $187.0K | $186.0K | $187.0K | $186.0K | $188.0K | $195.0K | · | $193.0K | $192.0K | |
| Paid-in Capital | $1.04B | $1.00B | $957M | $936M | $907M | $894M | $879M | $863M | $841M | $824M | $808M | $795M | $778M | · | $746M | $731M | |
| Retained Earnings | $-119M | $-51M | $21M | $158M | $117M | $187M | $151M | $95M | $73M | $80M | $61M | $85M | $225M | · | $203M | $170M | |
| AOCI | $-348.0K | $28.0K | $1M | $1M | $1M | $1M | $1M | $3M | $-1M | $-3M | $-5M | $-9M | $-12M | · | $-19M | $-22M | |
| Stockholders' Equity | $916M | $951M | $979M | $1.10B | $1.03B | $1.08B | $1.03B | $961M | $914M | $901M | $865M | $871M | $991M | $966M | $930M | $879M | |
| Liabilities + Equity | $1.08B | $1.12B | $1.16B | $1.26B | $1.20B | $1.26B | $1.17B | $1.12B | $1.07B | $1.08B | $1.00B | $1.03B | $1.15B | · | $1.07B | $1.03B | |
| Shares Outstanding | 179,849,000 | 183,060,000 | 184,992,000 | 188,090,000 | 187,453,000 | 188,875,000 | 187,584,000 | 186,781,000 | 185,704,000 | 186,562,000 | 186,175,000 | 188,518,000 | 194,649,000 | 193,941,000 | 193,252,000 | 192,302,000 |
现金流
| 指标 | 趋势 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $37M | $37M | $34M | $29M | $22M | $18M | $19M | $18M | $17M | $12M | $12M | $13M | $14M | $13M | $14M | $11M | |
| Deferred Tax | · | $32M | $0 | · | · | $-14M | $2M | · | · | $-9M | $0 | $0 | $0 | $4M | $9M | $0 | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Restructuring | · | · | · | · | · | $0 | $0 | $2M | · | $0 | $0 | $8M | · | $0 | $0 | $0 | |
| Other Non-cash | $-23M | · | · | · | $-16M | · | · | · | $-20M | · | · | · | $12M | · | · | · | |
| Operating Cash Flow | $42M | $110M | $61M | $94M | $62M | $98M | $65M | $68M | $41M | $64M | $50M | $13M | $57M | $47M | $49M | $40M | |
| CapEx | $62.0K | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $36.0K | $41.0K | $70.0K | $21.0K | $204.0K | $766.0K | |
| Investing Cash Flow | $113M | $138M | $38M | $-32M | $3M | $-24M | $-59M | $24M | $30M | $-76M | $40M | $-50M | $117M | $-13M | $13M | $-19M | |
| Stock Repurchased | $92M | $91M | $197M | $22M | $122M | $27M | $19M | $23M | $51M | $18M | $77M | $164M | $22M | $15M | $0 | $61M | |
| Net Stock Activity | $-92M | · | · | · | $-122M | · | · | · | $-51M | · | · | · | $-22M | · | · | · | |
| Financing Cash Flow | $-101M | $-93M | $-204M | $-30M | $-137M | $-30M | $-25M | $-20M | $-57M | $-14M | $-76M | $-161M | $-26M | $-12M | $779.0K | $-57M | |
| Net Change in Cash | $54M | $154M | $-104M | $32M | $-72M | $44M | $-19M | $73M | $15M | $-26M | $15M | $-198M | $149M | $22M | $63M | $-36M | |
| Taxes Paid | · | · | · | · | · | · | $14M | $9M | $13M | · | $9M | $29M | $0 | · | $2M | · | |
| Free Cash Flow | $42M | · | · | · | · | · | · | · | $41M | · | · | · | $57M | · | · | · |
盈利能力
| 指标 | 趋势 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 84.9% | · | 89.9% | 90.2% | 89.2% | · | 91.6% | 90.0% | 89.3% | · | 91.0% | 88.8% | 87.9% | · | 88.3% | 87.1% | |
| Operating Margin | 21.5% | · | 38.9% | 37.8% | 37.4% | · | 47.4% | 38.8% | 36.4% | · | 43.3% | 29.7% | 27.4% | · | 33.4% | 31.4% | |
| Net Margin | 15.5% | · | 33.3% | 36.8% | 36.5% | · | 44.6% | 32.3% | 32.7% | · | 35.4% | 26.9% | 26.2% | · | 29.0% | 25.7% | |
| Pretax Margin | 25.8% | · | 43.7% | 43.3% | 44.0% | · | 53.3% | 45.4% | 42.0% | · | 46.6% | 34.9% | 31.8% | · | 35.5% | 32.3% | |
| EBITDA Margin | 24.2% | · | 38.9% | 37.8% | 39.3% | · | 47.4% | 38.8% | 38.4% | · | 43.3% | 29.7% | 29.8% | · | 33.4% | 31.4% | |
| ROA | 2.1% | · | 5.3% | 5.2% | 4.7% | · | 6.9% | 4.1% | 3.7% | · | 4.6% | 3.0% | 2.6% | · | 3.4% | 2.8% | |
| ROE | 2.5% | · | 6.1% | 6.0% | 5.5% | · | 7.9% | 4.8% | 4.3% | · | 5.3% | 3.5% | 3.0% | · | 3.8% | 3.2% | |
| ROIC | 2.2% | · | 5.6% | 5.0% | 4.4% | · | 6.5% | 3.9% | 3.9% | · | 5.1% | 3.0% | 2.5% | · | 3.4% | 2.9% |
流动性与偿付能力
| 指标 | 趋势 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | · | 6.6 | 7.8 | 6.5 | · | 8.7 | 7.2 | 6.7 | · | 8.0 | 7.0 | 7.5 | · | 8.5 | 7.2 | |
| Quick Ratio | 3.0 | · | 1.5 | 2.1 | 1.7 | · | 2.6 | 2.3 | 1.7 | · | 2.1 | 1.7 | 3.0 | · | 2.0 | 1.3 |
效率
| 指标 | 趋势 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Receivables Turnover | 1.0 | · | 1.3 | 1.3 | 1.1 | · | 1.4 | 1.2 | 1.2 | · | 1.6 | 1.3 | 1.3 | · | 1.6 | 1.5 |
每股
| 指标 | 趋势 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.09 | · | $5.29 | $5.82 | $5.47 | · | $5.50 | $5.15 | $4.92 | · | $4.64 | $4.62 | $5.09 | · | $4.81 | $4.57 | |
| Revenue / Share | $0.82 | · | $0.93 | $0.84 | $0.73 | · | $0.83 | $0.68 | $0.64 | · | $0.67 | $0.54 | $0.51 | · | $0.54 | $0.48 | |
| Cash Flow / Share | $0.22 | · | · | · | $0.31 | · | · | · | $0.21 | · | · | · | $0.27 | · | · | · | |
| Cash / Share | $1.52 | · | $0.35 | $0.90 | $0.73 | · | $0.88 | $0.99 | $0.60 | · | $0.66 | $0.57 | $1.58 | · | $0.71 | $0.38 | |
| EPS (TTM) | $0.84 | · | $1.20 | $1.26 | $1.17 | · | $1.00 | $0.87 | $0.80 | · | $0.67 | $0.59 | $0.56 | · | $0.56 | $0.66 |
估值 (TTM)
| 指标 | 趋势 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $656M | · | $638M | $621M | $590M | · | $550M | $517M | $494M | · | $468M | $448M | $437M | · | $402M | $384M | |
| Net Income TTM | $167M | · | $239M | $253M | $235M | · | $201M | $174M | $161M | · | $138M | $123M | $119M | · | $119M | $141M | |
| Market Cap | $3.73B | · | $8.19B | $13.76B | $11.50B | · | $10.02B | $8.14B | $5.19B | · | $5.22B | $4.00B | $6.62B | · | $6.49B | $5.81B | |
| P/E | 24.7 | · | 36.9 | 58.1 | 52.4 | · | 53.4 | 50.1 | 35.0 | · | 41.9 | 36.0 | 60.8 | · | 59.9 | 45.8 | |
| P/S | 5.7 | · | 12.8 | 22.1 | 19.5 | · | 18.2 | 15.7 | 10.5 | · | 11.1 | 8.9 | 15.2 | · | 16.1 | 15.1 | |
| P/B | 4.1 | · | 8.4 | 12.6 | 11.2 | · | 9.7 | 8.5 | 5.7 | · | 6.0 | 4.6 | 6.7 | · | 7.0 | 6.6 | |
| P / Tangible Book | 4.7 | · | 9.6 | 14.2 | 12.3 | · | 10.7 | 9.4 | 6.3 | · | 6.8 | 5.2 | 7.4 | · | 7.8 | 7.5 | |
| P / Cash Flow | 88.8 | · | · | · | 185.2 | · | · | · | 125.9 | · | · | · | 115.8 | · | · | · | |
| Earnings Yield | 4.0% | · | 2.7% | 1.7% | 1.9% | · | 1.9% | 2.0% | 2.9% | · | 2.4% | 2.8% | 1.7% | · | 1.7% | 2.2% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
| 指标 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| 收入 | $645M | $570M | $475M | $419M | $344M |
| 毛利率 % | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% |
| 营业利润率 % | 33.3% | 39.9% | 34.5% | 29.9% | 33.1% |
| 净收入 | $196M | $223M | $148M | $113M | $155M |
| 稀释后每股收益 (EPS) | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 |
| 指标 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| 流动比率 | 6.1 | 7.0 | 6.2 | 7.0 | 8.1 |
| 速动比率 | 2.3 | 2.2 | 1.3 | 1.9 | 1.7 |
| 指标 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| 自由现金流 | $326M | $273M | $184M | $178M | $125M |
机构持有人 (13F) 411 家申报者 · $3.3B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 44 (-51 与上一季度对比) | 100 (-12 与上一季度对比) | 132 (-36 与上一季度对比) | 147 (+21 与上一季度对比) | +3.0M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $588281276 | 13285485 | 17.59% | 股份 |
| BlackRock, Inc. | $296729585 | 14307116 | 8.87% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $132468433 | 6387099 | 3.96% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $123971960 | 5977433 | 3.71% | 股份 |
| D. E. Shaw & Co., Inc. | $122826179 | 5922188 | 3.67% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $96385189 | 4647309 | 2.88% | 股份 |
| STATE STREET CORP | $87334253 | 4210909 | 2.61% | 股份 |
| GOLDMAN SACHS GROUP INC | $84762882 | 4086928 | 2.53% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $79848140 | 3849310 | 2.39% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $65022244 | 3135113 | 1.94% | 股份 |
| DEUTSCHE BANK AG\ | $60011895 | 2893534 | 1.79% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $59184680 | 2853649 | 1.77% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $55840936 | 2692427 | 1.67% | 股份 |
| Carmignac Gestion | $48861366 | 2355900 | 1.46% | 股份 |
| FEDERATED HERMES, INC. | $48345085 | 2331007 | 1.45% | 股份 |
| MORGAN STANLEY | $46575609 | 2245689 | 1.39% | 股份 |
| LOOMIS SAYLES & CO L P | $45345771 | 2186392 | 1.36% | 股份 |
| Squarepoint Ops LLC | $45090336 | 2174076 | 1.35% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $42902785 | 2068601 | 1.28% | 股份 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $42682967 | 1831887 | 1.28% | 股份 |
| Invesco Ltd. | $39908904 | 1924248 | 1.19% | 股份 |
| Amundi | $39467726 | 1902977 | 1.18% | 股份 |
| NORGES BANK | $39178461 | 1889029 | 1.17% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $37860213 | 1838767 | 1.13% | 股份 |
| Gotham Asset Management, LLC | $35523762 | 1712814 | 1.06% | 股份 |
| CITADEL ADVISORS LLC | $32385137 | 1561482 | 0.97% | 股份 |
| Iron Triangle Partners LP | $30401231 | 686568 | 0.91% | 股份 |
| AXA Investment Managers S.A. | $29339221 | 401083 | 0.88% | 股份 |
| Walleye Capital LLC | $29032972 | 1399854 | 0.87% | 股份 |
| BANK OF AMERICA CORP /DE/ | $28029302 | 1351461 | 0.84% | 股份 |
| Qube Research & Technologies Ltd | $26585445 | 1281844 | 0.80% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $24611432 | 1186665 | 0.74% | 股份 |
| NORTHERN TRUST CORP | $24398059 | 1176377 | 0.73% | 股份 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $24081214 | 1161100 | 0.72% | 股份 |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $21706360 | 1046594 | 0.65% | 股份 |
| CITIGROUP INC | $21132360 | 1018918 | 0.63% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $21106040 | 1017649 | 0.63% | 股份 |
| Swedbank AB | $20958994 | 1010559 | 0.63% | 股份 |
| UBS Group AG | $18868401 | 909759 | 0.56% | 股份 |
| JANE STREET GROUP, LLC | $18450221 | 889596 | 0.55% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $17517170 | 844608 | 0.52% | 股份 |
| JPMORGAN CHASE & CO | $16959200 | 817890 | 0.51% | 股份 |
| Bank of New York Mellon Corp | $16627817 | 801727 | 0.50% | 股份 |
| ALGERT GLOBAL LLC | $16161002 | 779219 | 0.48% | 股份 |
| BANK OF NOVA SCOTIA | $15850607 | 764253 | 0.47% | 股份 |
| CANADA PENSION PLAN INVESTMENT BOARD | $14559480 | 702000 | 0.44% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $13859558 | 668303 | 0.41% | 股份 |
| Fundsmith LLP | $13549940 | 653324 | 0.41% | 股份 |
| BAILLIE GIFFORD & CO | $13349820 | 643675 | 0.40% | 股份 |
| Glenmede Investment Management, LP | $13095165 | 179018 | 0.39% | 股份 |
公司内部人士 15 位内幕人士 · 8 位高管 · 6 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Jeffrey Tangney | Chief Executive Officer | 2026年8月15日 F | 2531955 | 0 | 0 | $0 |
| Matthew Sonefeldt | Chief Financial Officer | 2026年8月15日 F | 486238 | 0 | 0 | $0 |
| Anna Bryson | Chief Financial Officer | 2026年2月15日 F | 505549 | 0 | 0 | $0 |
| Steven L Zatz | President | 2026年9月24日 A | 204291 | 0 | 0 | $0 |
| Siddharth Sitaram | Chief Accounting Officer | 2026年9月15日 C | 96045 | 0 | 8 | $-419352 |
| Craig Overpeck | Senior Vice President, Commercial Operations | 2024年5月16日 S | 108609 | 0 | 0 | $0 |
| Paul W. Jorgensen | Chief Revenue Officer | 2023年2月15日 F | 313059 | 0 | 0 | $0 |
| Joseph B. Kleine | Chief Commercial Officer | 2022年1月12日 C | 441760 | 0 | 0 | $0 |
| Watkin Phoebe L. Yang | 董事 | 2026年9月30日 S | 24744 | 0 | 1 | $-34456 |
| Kira Scherer Wampler | 董事 | 2026年9月1日 C | 27923 | 0 | 9 | $-927380 |
| Regina M. Benjamin | 董事 | 2026年8月27日 A | 58987 | 0 | 1 | $-354200 |
| Kevin Spain | 董事 | 2026年8月27日 A | 11305 | 0 | 0 | $0 |
| Timothy S Cabral | 董事 | 2026年8月27日 A | 11305 | 0 | 2 | $-793325 |
| Andreas Stavropoulos | 10% 所有者 | 2021年6月28日 C | · | 0 | 0 | $0 |
| Gilbert H Kliman | · | 2022年8月2日 D | 449960 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
ETF持仓 由 80 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| GRPM · Invesco Exchange-Traded Fund Trust | 2.03% | 352435 SH | 2026年10月1日 | 每日 |
| LSEQ · Harbor ETF Trust | 2.02% | 14749 NS | 2026年7月31日 | N-PORT |
| FXH · First Trust Exchange-Traded Alpha... | 1.37% | 686526 NS | 2026年7月31日 | N-PORT |
| SMLL · Harbor ETF Trust | 1.35% | 9053 NS | 2026年7月31日 | N-PORT |
| RNIN · EA Series Trust | 1.13% | 98433 NS | 2026年7月31日 | N-PORT |
| MCOW · Pacer Funds Trust | 1.03% | 525 NS | 2026年7月31日 | N-PORT |
| XMHQ · Invesco Exchange-Traded Fund Trust | 0.73% | 1377723 SH | 2026年10月1日 | 每日 |
| BUL · Pacer Funds Trust | 0.49% | 30738 NS | 2026年7月31日 | N-PORT |
| IHF · iShares Trust | 0.48% | 257076 SH | 2026年9月11日 | 每日 |
| RFG · Invesco Exchange-Traded Fund Trust | 0.43% | 49865 SH | 2026年10月1日 | 每日 |
| COWG · Pacer Funds Trust | 0.33% | 349670 NS | 2026年7月31日 | N-PORT |
| CALF · Pacer Funds Trust | 0.32% | 557810 NS | 2026年7月31日 | N-PORT |
| ESUM · Strategy Shares | 0.18% | 15942 NS | 2026年7月31日 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.15% | 132035 SH | 2026年8月19日 | 每日 |
| QVMM · Invesco Exchange-Traded Fund Trus... | 0.14% | 19674 SH | 2026年10月1日 | 每日 |
| BKSE · BNY Mellon ETF Trust | 0.12% | 5010 NS | 2026年7月31日 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund ... | 0.12% | 25655 NS | 2026年7月31日 | N-PORT |
| EWUS · iShares Trust | 0.11% | 52582 SH | 2026年9月11日 | 每日 |
| VFQY · VANGUARD WELLINGTON FUND | 0.11% | 25965 SH | 2026年8月19日 | 每日 |
| EQAL · Invesco Exchange-Traded Fund Trus... | 0.11% | 30537 SH | 2026年10月1日 | 每日 |
| ESSC · Strategy Shares | 0.10% | 1770 NS | 2026年7月31日 | N-PORT |
| ISCG · iShares Trust | 0.10% | 39666 SH | 2026年9月11日 | 每日 |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.10% | 33755 NS | 2026年7月31日 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.08% | 97882 NS | 2026年7月31日 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.08% | 76205 SH | 2026年10月1日 | 每日 |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.08% | 215901 SH | 2026年8月19日 | 每日 |
| PTMC · Pacer Funds Trust | 0.08% | 14760 NS | 2026年7月31日 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.07% | 1747294 SH | 2026年8月19日 | 每日 |
| MIDU · Direxion Shares ETF Trust | 0.06% | 1965 NS | 2026年7月31日 | N-PORT |
| IYH · iShares Trust | 0.05% | 77403 SH | 2026年9月11日 | 每日 |
| ESML · iShares Trust | 0.05% | 56863 SH | 2026年9月11日 | 每日 |
| VFVA · VANGUARD WELLINGTON FUND | 0.05% | 21465 SH | 2026年8月19日 | 每日 |
| SMMD · iShares Trust | 0.04% | 69284 SH | 2026年9月11日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.04% | 362894 SH | 2026年8月19日 | 每日 |
| SMDX · Tidal Trust III | 0.04% | 2374 NS | 2026年7月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.04% | 57235 NS | 2026年7月31日 | N-PORT |
| WSML · iShares Trust | 0.03% | 53898 SH | 2026年9月11日 | 每日 |
| IEUS · iShares Trust | 0.03% | 67403 SH | 2026年9月11日 | 每日 |
| RWK · Invesco Exchange-Traded Fund Trus... | 0.03% | 14182 SH | 2026年10月1日 | 每日 |
| IWS · iShares Trust | 0.03% | 193300 SH | 2026年9月11日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 1537722 SH | 2026年8月19日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.03% | 3033009 SH | 2026年8月19日 | 每日 |
| IWR · iShares Trust | 0.02% | 538960 SH | 2026年9月11日 | 每日 |
| RILA · Spinnaker ETF Series | 0.02% | 446 NS | 2026年7月31日 | N-PORT |
| PDN · Invesco Exchange-Traded Fund Trus... | 0.02% | 68821 SH | 2026年10月1日 | 每日 |
| LRND · New York Life Investments ETF Trust | 0.02% | 2967 NS | 2026年7月31日 | N-PORT |
| SCZ · iShares Trust | 0.01% | 2047043 SH | 2026年9月11日 | 每日 |
| VSS · VANGUARD INTERNATIONAL EQUITY IND... | 0.01% | 2102305 SH | 2026年8月19日 | 每日 |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 78419 SH | 2026年8月19日 | 每日 |
| DXUV · Dimensional ETF Trust | 0.01% | 2526 NS | 2026年7月31日 | N-PORT |
| IUSG · iShares Trust | 0.01% | 114485 SH | 2026年9月11日 | 每日 |
| IWD · iShares Trust | 0.01% | 288768 SH | 2026年9月11日 | 每日 |
| IYY · iShares Trust | 0.00% | 5691 SH | 2026年9月11日 | 每日 |
| ITOT · iShares Trust | 0.00% | 179485 SH | 2026年9月11日 | 每日 |
| IWB · iShares Trust | 0.00% | 90563 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.00% | 36814 SH | 2026年9月11日 | 每日 |
| DFAC · Dimensional ETF Trust | 0.00% | 99952 NS | 2026年7月31日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 3539 NS | 2026年7月31日 | N-PORT |
| IEUR · iShares Trust | 0.00% | 334412 SH | 2026年9月11日 | 每日 |
| IDEV · iShares Trust | 0.00% | 905897 SH | 2026年9月11日 | 每日 |
| DFUS · Dimensional ETF Trust | 0.00% | 23098 NS | 2026年7月31日 | N-PORT |
| IEFA · iShares Trust | 0.00% | 4370632 SH | 2026年9月11日 | 每日 |
| DCOR · Dimensional ETF Trust | 0.00% | 3112 NS | 2026年7月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 10812 NS | 2026年7月31日 | N-PORT |
| IXUS · iShares Trust | 0.00% | 862826 SH | 2026年9月11日 | 每日 |
| TILT · FlexShares Trust | 0.00% | 158 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 4200411 SH | 2026年8月19日 | 每日 |
| VXUS · VANGUARD STAR FUNDS | 0.00% | 7970190 SH | 2026年8月19日 | 每日 |
| VGK · VANGUARD INTERNATIONAL EQUITY IND... | 0.00% | 1396695 SH | 2026年8月19日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | 0.00% | 598294 SH | 2026年8月19日 | 每日 |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.00% | 5431499 SH | 2026年8月19日 | 每日 |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.00% | 22610 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 10642 SH | 2026年8月19日 | 每日 |
| VSGX · VANGUARD WORLD FUND | 0.00% | 95335 SH | 2026年8月19日 | 每日 |
| ESGV · VANGUARD WORLD FUND | 0.00% | 29384 SH | 2026年8月19日 | 每日 |
| IJH · iShares Trust | · | 4694508 SH | 2026年9月11日 | 每日 |
| IJK · iShares Trust | · | 774827 SH | 2026年9月11日 | 每日 |
| XJH · iShares Trust | · | 18322 SH | 2026年9月8日 | 每日 |
| ISCB · iShares Trust | · | 5605 SH | 2026年9月11日 | 每日 |
| SMLF · iShares Trust | · | 103220 SH | 2026年9月11日 | 每日 |
DOCS 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
12个月价格目标
18 位分析师 · 2026-10-03平均目标 $29.67 +6.2%
同行比较(GICS 子行业) 关键指标与行业同行对比
财年依据,价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| DOCS | $4.27B | 23.8 | 13.1% | 30.4% | 19.2% | 89.1% |
| VEEV | $33.40B | 37.5 | 16.3% | 28.4% | 13.1% | 75.5% |
| WAY | $6.27B | 53.7 | 16.5% | 10.2% | 3.2% | · |
| HTFL | $2.49B | -9.2 | 39.9% | -66.3% | 39.3% | 76.8% |
| SDGR | · | -12.7 | 23.3% | -40.4% | -29.2% | 55.7% |
| CERT | $1.40B | -881.0 | 8.8% | -0.38% | -0.15% | · |
| GDRX | · | 30.1 | 0.57% | 3.8% | 4.8% | · |
| TDOC | $1.25B | -6.1 | -1.5% | -7.9% | -14.3% | · |
| HSTM | $682M | 37.8 | 4.3% | 6.0% | 5.2% | · |
| PHR | · | 335.8 | 14.5% | 0.48% | 0.73% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存,并会跟随您浏览所有股票。